Here's Eli Lilly's Competitive Advantage in GLP-1 Obesity Drugs and Abbott's Supporting Role
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
NASDAQ Composite
Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
January was great for stocks: here are our five best-performing companies of the month
Benchmarks hit record highs as stocks advanced during a busy earnings season.
The US economy of 2023, in graphs
A pedestrian holds an umbrella as he walks along a street in the rain in Times Square, New York, on…